These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 17291487

  • 1. Cannabinoid CB1 receptor antagonism markedly increases dopamine receptor-mediated stereotypies.
    Ferrer B, Gorriti MA, Palomino A, Gornemann I, de Diego Y, Bermudez-Silva FJ, Bilbao A, Fernandez-Espejo E, Moratalla R, Navarro M, Rodríguez de Fonseca F.
    Eur J Pharmacol; 2007 Mar 22; 559(2-3):180-3. PubMed ID: 17291487
    [Abstract] [Full Text] [Related]

  • 2. Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors.
    Martín AB, Fernandez-Espejo E, Ferrer B, Gorriti MA, Bilbao A, Navarro M, Rodriguez de Fonseca F, Moratalla R.
    Neuropsychopharmacology; 2008 Jun 22; 33(7):1667-79. PubMed ID: 17957223
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors.
    Dall'Olio R, Gaggi R, Voltattorni M, Tanda O, Gandolfi O.
    Behav Pharmacol; 2002 Dec 22; 13(8):633-8. PubMed ID: 12478213
    [Abstract] [Full Text] [Related]

  • 5. Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists.
    Berridge KC, Aldridge JW.
    Synapse; 2000 Sep 01; 37(3):194-204. PubMed ID: 10881041
    [Abstract] [Full Text] [Related]

  • 6. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum.
    Giuffrida A, Parsons LH, Kerr TM, Rodríguez de Fonseca F, Navarro M, Piomelli D.
    Nat Neurosci; 1999 Apr 01; 2(4):358-63. PubMed ID: 10204543
    [Abstract] [Full Text] [Related]

  • 7. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H, Sato H, Ida I, Oshima A, Sakurai N, Shihara N, Horikawa Y, Mikuni M.
    Pharmacol Biochem Behav; 2007 May 01; 87(1):56-64. PubMed ID: 17499349
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects on turning of microinjections into basal ganglia of D(1) and D(2) dopamine receptors agonists and the cannabinoid CB(1) antagonist SR141716A in a rat Parkinson's model.
    El-Banoua F, Caraballo I, Flores JA, Galan-Rodriguez B, Fernandez-Espejo E.
    Neurobiol Dis; 2004 Jul 01; 16(2):377-85. PubMed ID: 15193294
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS, Joyce JN.
    Dev Psychobiol; 1998 May 01; 32(4):313-26. PubMed ID: 9589220
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
    Cauli O, Morelli M.
    Psychopharmacology (Berl); 2002 Jul 01; 162(3):246-54. PubMed ID: 12122482
    [Abstract] [Full Text] [Related]

  • 15. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
    Rowlett JK, Platt DM, Yao WD, Spealman RD.
    J Pharmacol Exp Ther; 2007 Jun 01; 321(3):1135-43. PubMed ID: 17351103
    [Abstract] [Full Text] [Related]

  • 16. A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia.
    Peng RY, Mansbach RS, Braff DL, Geyer MA.
    Neuropsychopharmacology; 1990 Jun 01; 3(3):211-8. PubMed ID: 2141986
    [Abstract] [Full Text] [Related]

  • 17. Blockade of globus pallidus adenosine A(2A) receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D(1) or D(2) dopamine receptor agonists.
    Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M.
    Synapse; 2008 May 01; 62(5):345-51. PubMed ID: 18297692
    [Abstract] [Full Text] [Related]

  • 18. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
    Zhou LW, Qin ZH, Weiss B.
    Neuropsychopharmacology; 1991 Jan 01; 4(1):47-55. PubMed ID: 1672250
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
    Johnson KB, Criswell HE, Jensen KF, Simson PE, Mueller RA, Breese GR.
    J Pharmacol Exp Ther; 1992 Aug 01; 262(2):855-65. PubMed ID: 1354257
    [Abstract] [Full Text] [Related]

  • 20. An automated method for the assessment of spontaneous and stereotyped climbing behavior in mice. Effects of the selective D1- and D2-dopamine receptor agonists SKF-38393 and RU-24926 and their association.
    Simon P, Charpentier S, Costentin J.
    Methods Find Exp Clin Pharmacol; 1991 Mar 01; 13(2):99-104. PubMed ID: 1830125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.